10.75

3.97% +0.41

After Hours: 10.73 -0.02 -0.19%

Sera Prognostics Inc (SERA)

Overview News Price History Discussions Forecast

Sera Prognostics Inc stock is currently priced at $10.75, with a 24-hour trading volume of 59,110. It has seen a +3.97% increased in the last 24 hours and a +13.16% rose in the past month. The chart indicates a potential bullish trend, as the stock is above the $10.15 pivot point. If it approaches the $11.12 resistance level, significant changes may occur.

Previous Close:

$10.34

Open:

$10.28

24h Volume:

59,110

Market Cap:

$350.89M

Revenue:

$306.00K

Net Income/Loss:

$-36.24M

P/E Ratio:

-8.0224

EPS:

-1.34

Net Cash Flow:

$-27.32M

1W Performance:

+10.26%

1M Performance:

+13.16%

6M Performance:

+503.93%

1Y Performance:

+228.75%

1D Range:

$10.07

$10.90

52W Range:

$1.52

$11.32

Sera Prognostics Inc Stock (SERA) Company Profile

Name

Sera Prognostics Inc

Sector

Healthcare (1191)

Industry

Diagnostics & Research (66)

Phone

801 990 0520

Address

2749 East Parleys Way, Suite 200, Salt Lake City

Employee

Twitter

Next Earnings Date

2022-11-09T21:00:00.000Z

Latest SEC Filings

SERA's Discussions on Twitter

Sera Prognostics Inc Stock (SERA) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Mar-30-22	Downgrade	Citigroup	Buy → Neutral
Nov-19-21	Initiated	Oppenheimer	Outperform
Oct-15-21	Resumed	Cowen	Outperform

Sera Prognostics Inc Stock (SERA) Latest News

Why JPMorgan Shares Are Trading Lower By Around 5%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Benzinga

Sera Prognostics (SERA) Upgraded to Buy: Here's What You Should Know

Zacks Investment Research

Aehr Test Systems Reports Preliminary Results, Joins Dyne Therapeutics, United Airlines And Other Big Stocks Moving Lower On Monday

Benzinga

Sera Prognostics Inc Stock (SERA) Financials Data

Sera Prognostics Inc (SERA) Revenue 2024

SERA reported a revenue (TTM) of $306.00 thousand for the quarter ending December 31, 2023, a +14.18% rise year-over-year.

Sera Prognostics Inc (SERA) Net Income 2024

SERA net income (TTM) was -$36.24 million for the quarter ending December 31, 2023, a +17.98% increase year-over-year.

Sera Prognostics Inc (SERA) Cash Flow 2024

SERA recorded a free cash flow (TTM) of -$27.32 million for the quarter ending December 31, 2023, a +22.84% increase year-over-year.

Sera Prognostics Inc (SERA) Earnings per Share 2024

SERA earnings per share (TTM) was -$1.16 for the quarter ending December 31, 2023, a +18.88% growth year-over-year.

Sera Prognostics, Inc., a health diagnostic company, discovers, develops, and commercializes biomarker tests for the early prediction of preterm birth risk and other complications of pregnancy. It develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in asymptomatic singleton pregnancies. The company was incorporated in 2008 and is headquartered in Salt Lake City, Utah.